Fabre, Stéphanie
Clerson, Pierre
Launay, Jean-Marie
Gautier, Jean-François
Vidal-Trecan, Tiphaine
Riveline, Jean-Pierre
Platt, Adam
Abrahamsson, Anna
Miner, Jeffrey N.
Hughes, Glen
Richette, Pascal
Bardin, Thomas
Funding for this research was provided by:
AstraZeneca
Article History
Received: 30 December 2017
Accepted: 28 March 2018
First Online: 2 May 2018
Ethics approval and consent to participate
: The study was approved by the ethics committee of Paris 7 university. Patients received a written information sheet with details on the study. All gave informed consent before any study procedure. A subset of patients agreed to sign a specific informed consent for LC-MS measurement.
: AA, AP, and GH are employees of AstraZeneca, and JNM was an employee of Ardea Biosciences, a wholly owned subsidiary of AstraZeneca at the time of this work. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.